Objective: This review summarises the effects of lactic acid bacteria on lactose malabsorption, bacterialaviral or antibiotic associated diarrhoea, and describes the impact of lactic acid bacteria on cancer and the fermentative products in the colon. Results: Eight studies (including 78 patients) demonstrated that lactase de®cient subjects absorbed lactose in yogurt better than lactose in milk, while two studies (25 patients) did not support this. Two studies (22 patients) showed that unfermented acidophilus milk was absorbed better than milk, while six studies (68 patients) found no signi®cant differences. Addition of lactose hydrolysing enzyme, lactase, to milk improved lactose malabsorption in seven studies (131 lactose malabsorbers), while one study (10 malabsorbers) demonstrated no improvement. Lactic acid bacteria alleviated travellers' diarrhoea in one study (94 individuals) while a study including 756 individuals was borderline statistically signi®cant. One study (50 individuals) did not ®nd an effect of lactic acid bacteria on travellers' diarrhoea. Six studies (404 infants) demonstrated a signi®cant effect of lactic acid bacteria on infant diarrhoea, while one study (40 infants) did not. Lactic acid bacteria moderated antibiotic associated diarrhoea in three studies (66 individuals), while two studies (117 individuals) were insigni®cant. Conclusions: Lactase de®cient subjects bene®t from a better lactose absorption after ingestion of yoghurt compared with milk and from milk added lactase, whereas ingestion of unfermented acidophilus milk does not seem to improve lactose absorption. The majority of studies support that lactic acid bacteria alleviate bacterialaviral induced diarrhoea, especially in infants, while the effect on antibiotic associated diarrhoea is less clear.
Introduction
Interest in the bene®cial effects of lactic acid bacteria dates to the Russian scientist, E. Metchnikoff (1845 Metchnikoff ( ± 1919 , who proposed that the extended longevity of the Balkan people could be attributable to their practice of ingesting fermented milk products (Metchnikoff, 1908) . He believed that gastrointestinal disturbances occur by intestinal growth of putrefactive microbes, and that lactic acid bacteria could minimise or prevent the harmful effects of these microbes. The role of lactic acid bacteria within the gastrointestinal tract has been one of the most controversial subjects of the area of intestinal microbial ecology. No other group of bacteria has been proposed to be responsible for so many different bene®cial actions, but non-conclusive or insigni®cant results are often reported when attempts are made to con®rm that lactic acid bacteria improve the health of the host.
Lactic acid bacteria consists of heterogeneous group of gram-positive bacteria, whose main fermentation product from carbohydrate is lactate. The group comprises cocci (streptococcus, pediococcus, leuconostoc) and rods (lactobacillus and bi®dobacterium), which are either exclusively (homofermentative) or at least 50% (heterofer-mentative) lactate producers (Kandler, 1983, Table 1 ).
Studies on the¯ora of the gastrointestinal tract report that numbers of bi®dobacteria may exceed 10 11 per gram of faeces (Finegold et al, 1983) accounting for 6 ± 25% of all cultivable bacteria in faeces (Kitsuoka, 1984; Scardovi, 1986) whereas lactobacilli only constitute 0 ± 1% of the bacteria in the faeces of healthy humans (Hill & Drasar, 1975; Gorbach, 1971; , Brown, 1977 . The exception of this condition is the dominant presence of bi®dobacteria in breast-fed infants (Stark & Lee, 1982) . Lactic acid bacteria are described to be of nutritional and therapeutic bene®t to the host in several clinical conditions. The proposed effects of lactic acid bacteria on the intestinal tract are mentioned in Table 2 . Discussion of these speci®c health targets follow.
Lactic acid bacteria supposedly exert an impact on the small as well as the large intestine. First, bacterial derived lactase from ingested lactic acid bacteria might enhance the hydrolysis of lactose to glucose and galactose in the small intestine, which are rapidly absorbed or fermented. Secondly, lactic acid bacteria may have an impact on the colonic¯ora in situations in which some sort of imbalance exists. The exact nature of this microbial imbalance and how it is corrected by the ingestion of lactic acid bacteria is not known.
Over the past decade there has been increased interest in bacterial food supplements, called probiotics. The de®ni-tion of a probiotic being:`A live microbial feed supplement which bene®cially affects the host animal by improving its intestinal microbial balance' (Fuller, 1989) . There are several characteristics that are of importance for organisms used as probiotics (Kim, 1988) . These include: the organism should maintain viability and activity in the carrier food before consumption, should survive the upper gastrointestinal tract, be capable of surviving and growing in the intestine, be a normal inhabitants of the intestinal tract, and eventually produce bene®cial effects when in the intestinal tract. Further, the organism must be non-pathogenic and non-toxic.
Survival through the gastrointestinal tract
The effect of lactic acid bacteria in the intestine requires that the bacteria or at least their enzymes survive the acid gastric content and are active after the passage of the stomach. Studies of orally administered lactic acid bacteria have demonstrated that the lactic acid bacterial counts in the small intestine increase signi®cantly after ingestion . The ability of Bi®dobacter-ium bi®dum to survive the passage through the upper gastrointestinal tract when ingested in fermented milk was investigated by Pochart et al (1992) using in vivo ileal perfusion, and he found that the average number of bi®dobacteria recovered from the terminal ileum constituted approximately 25% of the number ingested (ingested dose 10 10 bacteria). This is in consistency with a study of ileotomic patients ingesting lactic acid bacteria, where bi®dobacteria were cultured from ileostomic contents in eight of nine ileostomists within six hours oral administration of 10 10 bacteria, while not present in the ileostomy ef¯uents of patients during control sampling (Hove et al, 1994) . Similarly, faecal levels of speci®c strains of lactic acid bacteria increase after ingestion. Goldin et al (1992) followed the excretion of Lactobacillus gg in faeces 3 and 7 d after subjects consumed 10 11 of Lactobacillus gg as either concentrate or as a whey drink. Strain gg increased 4 ± 6 log cycles in almost all subjects, and remained present in faeces 7 d after feeding stopped. These results have also been obtained with bi®dobacteria , where intake of marked bi®dobacteria resulted in a rise in faecal levels to approximately 10 8 bi®dobacteriaag faeces followed by a gradual decrease after ingestion ceased. Thus, attempts to increase the number of lactic acid bacteria in the gastrointestinal tract by ingestion generally results in a temporary colonisation of the gut, which persists as long as the lactic acid bacteria are ingested (Goldin et al, 1992; Deneke et al, 1988; Saxelin et al, 1991) . After consumption of a bacterium, recovery from the faeces is not evidence of implantation, even if recovery persists for a period after consumption has stopped. Continued faecal recovery of ingested lactic acid bacteria may be because of residence time in the large intestine that exceeds microbial generation time.
Impact on the small intestine

Relieving lactose intolerance in lactose malabsorbers
Lactose is the predominate carbohydrate in milk, and it requires enzymatic hydrolysis to the monosaccharides glucose and galactose before intestinal absorption. Small intestinal epithelial cells (enterocytes) produce b-galactosidase in childhood, and some people continue to produce b-galactosidase throughout life, but globally most adults are lactose malabsorbers and are as non-milk consumers deprived of an important source of protein and calcium. Although lactose malabsorption is common worldwide, the symptomatic expression of lactose intolerance is less so. Lactose intolerance has a substantial psychological component: among individuals who believed they were lactose malabsorbers 64% were shown to be lactose digesters (Rosado et al, 1987) ; most lactase-de®cient people can consume one glass of milk per day asymptomatically (Savaiano & Kotz, 1988) , and 85% of individuals with discomfort have only mild symptoms (Scrimshaw & Murray, 1988) .
Carbohydrate malabsorption increases the delivery of unabsorbed carbohydrates to the colon bacteria and results in increased intestinal production and respiratory excretion of hydrogen. Breath hydrogen excretion is therefore used as an indicator of malabsorption of simple carbohydrates as disaccharides (Welsh et al, 1981) . A dose-response relationship between breath hydrogen excretion and the amount Rumessen et al (1990) , while breath hydrogen excretion is of limited value in the evaluation of malabsorption of complex dietary carbohydrates (Nordgaard et al, 1995) . The geographic incidence of lactose malabsorption is shown in Figure 1 (Gudmand-Hùyer & Skovbjerg, 1996) .
Yogurt is made from milk enriched with milk proteins (to improve consistency), which is incubated with two or three species of lactic acid bacteria (that is L. bulgaricus and S. thermophilus) at 42 C until the pH drops to approximately 4.5 (Martini et al, 1987) . The resulting yogurt is cooled and stored until use.
In contrast to yogurt, sweet acidophilus milk is unfermented, made by adding high concentrations of viable L. acidophilus cells to cold milk. In storage below 5 C L. acidophilus do not multiply and thus, sweet acidophilus milk has the bene®ts of lactase activity, without the acid taste of the corresponding fermented product (Martini et al, 1991) .
It seems evident that lactose intolerant individuals are able to substitute fermented milk (yogurt) for fresh milk, Table 3 (a).
The rational for using fermented milk relates to the fact that lactose content is reduced between 25 and 50 percent during the fermented process (McDonough et al, 1987; Gorbach, 1990) . Reduced malabsorption may, however, not only be associated with the decreased lactose concentration, but also to high lactase activities in yogurt (Kolars et al, 1984 . In considering how much of the improved digestion was due to reduction in lactose and how much was due to ingested lactase supplied by the cultures, the following investigations were performed (Table 4) .
When yogurt was heated in order to inactivate lactase, malabsorption measured by breath hydrogen test was still signi®cantly lower than after milk ingestion. Since both products had little or no lactase activity, it was assumed that the difference was due to reduced lactose in the heated yogurt (McDonough et al, 1987) . Similarly, when lactose was added to yogurt so that lactose concentration was equal to that in milk, the mean breath hydrogen value was signi®cantly lower than the value for milk, thus indicating a response to lactase activity (McDonough et al, 1987) . This was further substantiated by adding commercial lactase to heated yogurt, in an amount that produced an activity level comparable to that found in yogurt, resulting in signi®cantly lower breath hydrogen test than for heated yogurt. With similar lactose content and lactase activity in heated yogurt added lactase and in yogurt, the two products Figure 1 Prevalence of adult lactose malabsorption in Europe in percent (Gudmand-Hùyer & Skovbjerg, 1996) . (Reprinted by permission of the author and Scandinavian University Press). (McDonough et al, 1987) . The majority of studies (Table 3a) support that yogurt enhances absorption of lactose when compared with equivalent amounts of lactose in milk. The improved tolerance of lactose when consumed as yogurt containing active live cultures is at least in part related to the inherent galactosidase activity of the yogurt bacteria, which hydrolyse a part of the ingested lactose (Kotz et al, 1994; Scherma Èk et al, 1995; Sanders, 1993) .
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In spite of similar average values for the area under the breath hydrogen curve, yogurt and heated yogurt was associated with a delay in the time to breath hydrogen rise and the time to peak breath hydrogen when compared with milk (Sherma Èk et al, 1995) , and studies have demonstrated a relationship between the rate of rise in breath hydrogen excretion and the severity of gastrointestinal symptoms (Dehkordi et al, 1995; Sherma Èk et al, 1995) .
In contrast to the above mentioned results, lactose intolerant individuals who ingest an unfermented milk product containing lactic acid bacteria (sweet acidophilus milk) with low concentration of bacterial lactase have no apparent bene®t from this as compared with milk, Table 3 (b), and Table 4 . If, however, the bacterial cell-membranes are damaged by sonication, and intracellular lactase is released, breath hydrogen values were found in the same low level as for heated yogurt (McDonough et al, 1987) . Thus, it seems that the bacterial lactase is not available or is insuf®cient to exert a measurable effect in sweet acidophilus milk during digestion, but can be made accessible after disruption of the cell membrane (Kolars et al, 1984; McDonough et al, 1987) . In accordance, an increase in microbial galactosidase of yogurt, enhance lactose absorption compared with conventional yogurt (Kotz et al, 1994) . These results are not supported by Kim & Gilliland 1983) and Lin et al (1991) , but are in accordance with Hove et al (1994) , who did not ®nd an improved lactose utilisation in lactase de®cient subjects after intake of large amounts of B. bi®dum (4.2Á10 10 cells). The ingestion of commerical lactase (often of yeast origin) either together with, immediately before or within 5 minutes after milk consumption (meal-time treated milk) is reported to improve lactose utilisation in most studies, while refuted in a single study (Onwulata et al, 1989) , (Table 5) . Milk treated with a commercial lactase preparation 20 ± 24 h prior to ingestion is approximately 90% hydrolysed . This milk has therefore a sweeter taste than regular milk. Aspects of lactic acid cultures effect on lactose digestion in lactose malabsorbers are discussed in detail in review articles (Gorbach, 1990;  Lactase activity was determined by measuring the amount of glucose released on hydrolysis during incubation at 37 C for 2 hours. Values are means of triplicate analysis. Lactic acid bacteria H Hove et al Sanders, 1993; Gurr, 1987 , Fuller, 1989 , Shahani & Ayebo, 1980 Bengmark, 1998) .
Prophylaxis against E. coli and antibiotic associated diarrhoea
Although the intestinal¯ora is a very steady ecosystem, the balance can be disturbed by a number of factors such as bacteria, viruses and antibiotics.
Travellers from United States and Northern Europe often suffer diarrhoea when visiting less developed regions of the world. The clinical picture varies from a short and mild attack with watery diarrhoea to a severe incapacitating disease with a duration of more than a week. In 40 ± 70% of the cases the etiological agent is enterotoxigenic Escherichia coli (E. coli) (Merson et al, 1976; Gorbach et al, 1975) . It is well established that travellers' diarrhoea to a great extent can be prevented by prophylactic intake of antibiotics, which have been reported to provide protection rates in the range of 60 ± 95% (DuPont et al, 1986; Sack, 1986) . The use of these agents may cause adverse reactions and lead to emergence of resistant bacterial strains. Therefore, the effect of lactic acid bacteria and other probiotics in promoting gastrointestinal health by inhibiting or eliminating enteric pathogens have been investigated.
Numerous publications based on uncontrolled clinical observations have suggested a role for lactic acid bacteria in the prevention of diarrhoea (Beck & Necheles, 1961; Winkelstein, 1955) , and several preparations of lactic acid bacteria (Paraghurt 1 , Trevis 1 , Biotura 1 ) are available without prescription as prophylaxis against diarrhoea. ). No signi®cant differences were noted with respect to attack rate, incubation period, duration of diarrhoea, volume or number of liquid stools (Clements et al, 1981) , (Table 6 (c)). On the contrary, a prospective double blind investigation of travellers' diarrhoea in 94 tourists travelling to Egypt found that daily intake of 10 10 lactic acid bacteria (L. acidophilus, B. bi®dum, L. bulgaricus, S. thermophilus) signi®cantly reduced the incidence of diarrhoea compared to the placebo treated group (17 cases of diarrhoea in the lactic acid bacteria treated group in comparison with 29 in the placebo treated group, P 0.02) (Black et al, 1989) , Table 6 (a).
Rotavirus is a common cause of non-bloody diarrhoea in children accounting for 50 ± 75 percent of episodes of acute diarrhoea in children below 3 y referred to the hospital (Guarino et al, 1997; . No speci®c therapy is available for rotavirus, and treatment is limited to rehydration. Probiotics has been suggested as a mode of preventing or moderating the infection. The group of Isolauri et al (1991) has reported a positive effect of a human lactic acid bacterial species, Lactobacilli casei strain gg, on the recovery from acute rotavirus induced diarrhoea in children. The children were randomised to either a lactic acid bacteria fermented milk product containing 10 10 ± 11 Lactobacillus casei, a Lactobacillus casei freeze-dried powder (10 10 ± 11 ), or placebo (pasteurised yogurt with only trace amounts of live lactic acid bacteria). The mean duration of diarrhoea after commencing the therapy was signi®cantly shorter in the two groups receiving live lactic acid bacteria in comparison with the placebo group, P`0.001. Analysis of speci®c antibody-secreting cells among circulating lymphocytes revealed that lactic acid bacterial therapy resulted in an augmentation of the local immune defence re¯ected in an IgA speci®c antibody-secreting cell response to rotavirus (Kaila et al, 1992) .
The use of lactic acid bacteria as prophylaxis against E. coli diarrhoea is supported by both in vitro and in vivo animal studies. Investigations using rabbit ileal loops have shown that lactic acid bacteria signi®cantly reduce the¯uid retention caused by enterotoxigenic E. coli (Foster et al, 1980; Johnson & Calia, 1979) . The reduced¯uid accumulation depended on the administration of a large dose of lactic acid bacteria (10 8 abacteria), whereas the individual ingredients in the lactic acid bacterial preparation did not demonstrate any anti¯uid response.
In vivo studies of 28 piglets placed in pens, contaminated with enterotoxigenic E. coli demonstrated that prophylactic feeding with lactic acid bacteria (10 9 ad) signi®cantly reduced the mortaility of E. coli enteropathy (1a14 in treatment group in comparison to 7a14 in the control group) (Nielsen et al, 1988) . Further, the average daily weight gain (0 ± 14 d post weaning) was signi®cantly Lactinex is a commercial preparation of dried viable L. acidophilus and L. bulgaricus in equal proportions (5Á10 8 bacteriaa1 g (Tankanow et al, 1990) ). Abbreviations: No. indiv. with diarr.ano. indiv.: Number of individuals with diarrhoeaatotal number of individuals; DB.: double blind; R.: randomised; bact.:bacteria; *): both oral andaor injectable ampicillin against infectious disease other than diarrhoea; **) positive test for C dif®cile cytotoxin in the stool; m: months.
Lactic acid bacteria H Hove et al higher in the treatment group (231 g) compared to the surviving control group (101 g).
Similar convincing results has been reported by Underdahl et al (1982) . When Streptococcus faecium were fed to gnotobiotics (animals which are obtained by hysterotomy and kept under sterile conditions and therefore have no intestinal¯ora) to prevent E. coli induced diarrhoea. Pigs fed S. faecium and challenge exposed with E. coli developed mild diarrhoea, but none of the pigs died, and they continued to eat well and gained weight. Pigs given E. coli only, developed severe diarrhoea and lost weight, and 5 of 8 infected pigs died.
How lactic acid bacteria diminish diarrhoeal disease is not known. One proposed mechanism is competitive colonisation. Competitive colonisation occurs when one intestinal microbe interferes with the colonisation of another. But documentation of this phenomenon by observing lactic cultures displacing pathogens or preventing pathogen adherence has been dif®cult experimentally.
Other studies have demonstrated that lactic acid bacteria stimulate macrophage phagocytosis of viable Salmonella (Hatcher & Lambrecht, 1993) , enhance IgA production in intestinal secretions (Perdigon et al, 1990) , produce an antimicrobial substance (Shahani & Ayebo, 1980; Silvia et al, 1987) , inhibit cell attachment and cell invasion by enterovirulent bacteria (Bernet et al, 1994) , and decrease intestinal permeability for macromolecules during rotavirus induced diarrhoea (Isolauri et al, 1993) .
In conclusion, Table 6 shows that seven of nine studies since 1985, show an effect of lactic acid bacteria on a 5% signi®cance level while two studies show an effect on a 7% sign®cance level. Two early studies are insigni®cant. The overall impression left by the mentioned human studies is that lactic acid bacterial therapy can limit the course of diarrhoeal diseases, especially rotavirus diarrhoea (Table 6) . A possible explanation for the often found inconsistency of results may be the use of different species and subspecies of lactic acid bacteria with different af®nity towards the human intestine. Host speci®city in colonisation by individual species has been demonstrated: L. acidophilus, L. fermentum, and L. plantarum are commonly found in the faeces of humans, whereas L. bulgaricus, the organism used in combination with S. thermophilus to make yogurt, is unable to colonise the bowel. The speci®city is possibly related to the individual lactic acid bacteria ability to colonise mucosal surface by binding to epithelial cells. Variations in lactic acid bacterial preparations and storage of fermented products may also in¯uence results (Gorbach, 1990) .
The best results seem to have been obtained by using Lactobacillus gg (Isolauri et al, 1991 , Siitonen et al, 1990 , which is a lactobacillus strain initially isolated from healthy humans. The strain was originally selected for its tolerance to acid and bile and the ability to adhere to human small intestinal cells.
The results of lactic acid bacteria treatment against antibiotic associated diarrhoea are shown in Table 7 (a). Siitonen et al (1990) studied 16 subjects, who ingested 400 mg erythromycin three times daily for seven days together with either 125 ml Lactobacillus gg fermented yogurt or 125 ml pasteurised regular yoghurt. The subjects receiving Lactobacillus gg yogurt were colonised with these bacteria even during antibiotic treatment and had fewer daily defecations than the group ingesting pasteurised yoghurt, Table 7 . Further, usual side effects as abdominal distress, pain and¯atulence tended to be reduced in the lactic acid bacterial treated group, while the difference in faecal volumes was not signi®cantly different. In ®ve studies of antibiotic associated diarrhoea including 183 subjects, an alleviating effect of lactic acid bacteria ingestion was found in 3 studies including 66 individuals. Therefore, no convincing effect of lactic acid bacteria on antibiotic associated diarrhoea was demonstrated. The studies of C. dif®cile induced diarrhoea included only ®ve and four patients, allowing no conclusions to be drawn. Recent controlled studies have demonstrated that another probiotic, the yeast Saccharomyces bouradii, reduce the risk of recurrent Clostridium dif®cile associated disease (including patients with Clostridium dif®cile diarrhoea, colitis and pseudomembranous colitis (McFarland et al, 1994) ) and antibiotic associated diarrhoea (McFarland et al, 1995; Surawicz et al, 1989) .
Impact on colon
Prevention of colonic cancer
There is considerable interest in the metabolic activities of the intestinal micro¯ora, especially in relation to the aetiology of colon cancer. Epidemiological studies have suggested a correlation between intake of a`Western diet' abundant in beef, fat, and protein but low in ®bre, fruit, and vegetables, and the occurrence of colon cancer. Indeed, a positive correlation has been found in several countries between dietary factors such as meat and animal fat consumption and the incidence of large bowel cancer (Howel, 1975) . Finland is an exception, being a nation with a high per capita fat consumption and a relatively low incidence of colon cancer (Armstrong & Doll, 1975) . Dairy products, especially yogurt, are a common compound of the Finnish diet, and possibly as a result, the intestinal microora of the Finns harbours high numbers of lactic acid bacteria (International Agency for Research on Cancer, 1997) . In an attempt to explain these epidemiological ®ndings, alterations in the metabolic activity of the intestinal¯ora have been studied. The studies have involved measurements of key enzymes: b-glucuronidase, azoreductase, and nitroreductase, which catalyse the conversion of indirect acting carcinogens to proximal carcinogens in the large bowel (Goldin & Gorbach, 1984) . Oral supplementation of the diet with viable bile-resistant L. acidophilus of human origin caused a signi®cant decline in these three key-enzymes (Goldin & Gorbach, 1984; Gordin et al, 1980) . These results were only partly con®rmed by in a study where 9 subjects ingested lactic acid bacteria (L. acidophilus, B. bi®dum) for 3 weeks. He reported of unchanged levels of faecal azo-reductase and b-glucuronidase, while only nitroreductase decreased during the observation period.
The studies were extended in an animal model of colon cancer induced by the chemical carcinogen, 1,2-dimethylhydrazine dihydrochloride (DMH). The activation of DMH to a potent carcinogen occurs in the large intestine, and the bacterial enzyme-b-glucuronidase is involved in this process. Suppression of this enzyme might reduce DMH activation and subsequent tumour formation. In experiments DMH-treated animals with given L. acidophilus in powdered form and compared with controls These studies show that the addition of lactic acid bacteria to the diet may delay colon tumour formation by prolonging the induction, indicating that lactobacilli may slow tumor development in experimental animals. Lactic acid bacteria have shown antineoplastic properties in a variety of cancer cell lines of both human and animal origin. The literature substantiating this in vitro effect has increased tremendously over the last decade. In brief, lactic acid bacteria reduce tumour cell viability (McGroatry et al, 1988; Sekine et al, 1985; Reddy et al, 1973; Reddy et al, 1983; Kato et al, 1981) , suppress induced carcinogenesis in the liver and colon (Reddy & Riverson, 1993) , inhibit mutagenic activity (Hosono et al., 1986; Renner & Mu Èntzner, 1991) , and bind potent mutagenic metabolic compounds (Morotomi & Mutai, 1986 ) and food mutagen (Zhang et al, 1990) . However, in spite of a wealth of indirect evidence, no direct data have yet proven cancer suppression in humans, as a result of consumption of lactic cultures in fermented or unfermented dairy products.
High concentrations of faecal bile acids have also been associated with the development of colon cancer, and the lithocholic acidadeoxycholic acid ratio has been reported to be increased in patients with colon cancer compared to controls (Owen et al, 1987) . Ingestion of L. acidophilus for 6 weeks have been demonstrated to lower concentrations of total bile acid and deoxycholic acid (Lidbeck et al, 1991) , although the changes were not signi®cant.
Correcting of a colonic`imbalance' Lactic acid bacteria may have an impact on the colonic ora in situations where some sort of imbalance exists. The exact nature of this microbial imbalance and how it is corrected by the ingestion of lactic acid bacteria has not been substantiated. A prerequisite for an effect on the colonic¯ora is that a substantial number of ingested lactic acid bacteria reach the large bowel. The work of others Hove et al, 1984; Goldin et al, 1992; Saxelin et al, 1991; Lidbeck et al, 1991) indicate that ingested lactic acid bacteria do reach the caecum. It is, however, questionable whether an ingested dose of lactic acid bacteria in the range of 10 10 ± 11 bacteria is able to in¯uence the colonic¯ora, which number approximately 10 13 bacteria (10 11 g), a number of 100 ± 1000 times higher than the ingested amount of lactic acid bacteria. This question is even more pertinent in light of the widely held belief that a dietary culture, even one possessing in vitro adhering capabilities, is highly unlikely to displace any bacterial strain that colonises a healthy human intestinal tract (Savage, 1977) . Human gastrointestinal microbiology is notably a dif®cult ®eld to study because of limits on direct experimentation and the dif®cult physiological requirements of the intestinal microbes. As indicated by Tannock (1984) :`All investigators approaching the study of the normal¯ora of the gastrointestinal tract must sooner or later be horri®ed by the complexity of an ecosystem that contains about 500 species of bacteria most of which are technically dif®cult to work with under laboratory conditions'.
The ability of lactic acid bacteria to in¯uence the fermentation processes, that is changes in organic acid production was examined by investigation of the fermentative products of human ileostomic ef¯uent after ingestion of large quantities of B. bi®dum (Hove et al, 1994) . When in isolated culture, B. bi®dum had a speci®c fermentative pattern, but this pattern could not be reencountered in the ileostomic outputs of nine ileostomists after oral ingestion of large quantities of B. bi®dum.
As B. bi®dum, L. acidophilus had a speci®c fermentation pattern when in isolated culture, but after incubation in mixed lactic acid bacteriaafaecal incubations the speci®c pattern disappeared although L. acidophilus was added in unphysiological large amounts constituting 50 ± 90% of the total¯ora. The fermentation products in mixed L. acidophilusafaecal incubations were related to the type of added substrate rather than to the addition or not of acid bacteria (Hove et al, 1994) . This does not imply that lactic acid bacteria do not contribute to the organic acid formation in the mixed homogenates, but rather that the capability for saccharide fermentation represented by the added bacteria already exists in the faecal¯ora. New perspectives of modulating the colonic¯ora has recently been introduced by Gibson et al. (1995) , who showed that oral ingestion of a diet rich in the indigestible carbohydrates oligofrutose and inulin signi®cantly increases the number of bi®dobacteria. Therefore, the prospect of lactic acid bacteria therapy may be a change in diet which subsequently alters colonic¯ora rather than ingestion of cultures of lactic acid bacteria themselves.
Lactic acid bacteria as pathogenic organisms
Although infections with these organisms are rare, it has been reported that lactic acid bacteria may play a role in a variety of serious infections. These include endocarditis (Axelrod et al, 1973) , bacteraemia (Bayer et al, 1978) , gastrointestinal infections (Bourne et al, 1978) , and splenic abscess (Sherman et al, 1987) . A risk factor is immunosuppressive therapy (Sherman et al, 1987) and poor oral hygiene where dental procedures can cause endocarditis. Treatment of lactic acid bacterial infections can be dif®cult since eradication is complicated by the often deep-seated location, the antimicrobial resistance to antibiotics, and the problem in identifying the organisms and thereby to initiate apppropriate treatment (Sherman et al, 1987) . In a single case L. acidophilus ingestion has been associated with the development of D-lactic acidosis (Mason, 1986) .
Conclusion
Lactic acid bacteria appear to alleviate lactose malabsorption in lactose malabsorbers when administered in fermented dietary milk products (yogurt, Table 3 (a)), but not in infermented milk products (set acidophilus milk, Table  3 (b)). Lactic acid bacteria seem to shorten the course of infectious diarrhoea especially in infants with rotavirus diarrhoea (Table 6 (b) ) and reduce the risk of travellers' diarrhoea (Table 6 (a)). The ability of lactic acid bacteria to prevent antibiotic associated diarrhoea is less convincing, and results from studies of Clostridium dif®cile are preliminary and yet inconclusive. Experimental studies indicate an effect of lactic acid bacteria on human cell cancer lines, but clinical evidence is lacking.
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